Exploring the Occurrence Mechanism and Early-Warning Model of Phlebitis Induced by Aescinate Based on Metabolomics in Cerebral Infarction Patients

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2024 Jan 23

PMID 38260811

Authors

Zhipeng Wang

You Yin

Yuhui Mu

Lili Cui

Xinhua Song

Jianhua Zhuang

Shouhong Gao

Xia Tao

Wansheng Chen

Affiliations

Soon will be listed here.

Abstract

Objective: This study aims to explore the mechanism underlying the induction of phlebitis by aescinate and create an early-warning model of phlebitis based on metabolomics.

Methods: Patients with cerebral infarction enrolled had been treated with aescinate. Plasma samples were collected either before administration of aescinate, upon the occurrence of phlebitis, or at the end of treatment. Non-targeted metabolomics and targeted amino acid metabolomics were carried out to analyze metabolic profiles and quantify the metabolites.

Results: Untargeted metabolomics revealed six differential metabolites in baseline samples versus post-treatment samples and four differential metabolites in baseline samples from patients with or without phlebitis. Pathways of these differential metabolites were mainly enriched in amino acid metabolism. Ten differential amino acids with a VIP value of >1 were identified in the baseline samples, enabling us to distinguish between patients with or without phlebitis. A logistic regression model was constructed (AUC 0.825) for early warning of phlebitis of grade 2 or higher.

Conclusion: The occurrence of aescinate-induced phlebitis, which can be predicted early during onset, may be associated with perturbations of the endogenous metabolic profile, especially the metabolism of amino acids.

Citing Articles

Schisandrin B exerts anti-colorectal cancer effect through CXCL2/ERK/DUSP11 signaling pathway.

Sun J, Wang Z, Yun Y, Feng Y, Liu Z, Cui L Cancer Cell Int. 2025; 25(1):97.

PMID: 40089741 DOI: 10.1186/s12935-025-03727-9.

References

Higginson R, Parry A . Phlebitis: treatment, care and prevention. Nurs Times. 2011; 107(36):18-21. View

Moinard C, Maccario J, Walrand S, Lasserre V, Marc J, Boirie Y . Arginine behaviour after arginine or citrulline administration in older subjects. Br J Nutr. 2015; 115(3):399-404. DOI: 10.1017/S0007114515004638. View

Wijnands K, Meesters D, van Barneveld K, Visschers R, Briede J, Vandendriessche B . Citrulline Supplementation Improves Organ Perfusion and Arginine Availability under Conditions with Enhanced Arginase Activity. Nutrients. 2015; 7(7):5217-38. PMC: 4516994. DOI: 10.3390/nu7075217. View

Liberman K, Njemini R, Luiking Y, Forti L, Verlaan S, Bauer J . Thirteen weeks of supplementation of vitamin D and leucine-enriched whey protein nutritional supplement attenuates chronic low-grade inflammation in sarcopenic older adults: the PROVIDE study. Aging Clin Exp Res. 2019; 31(6):845-854. PMC: 6583678. DOI: 10.1007/s40520-019-01208-4. View

Yang Y, Wang Z, Li X, Lv J, Zhong R, Gao S . Profiling the metabolic disorder and detection of colorectal cancer based on targeted amino acids metabolomics. J Transl Med. 2023; 21(1):824. PMC: 10655464. DOI: 10.1186/s12967-023-04604-7. View

Obi A, Stringer K, Diaz J, Finkel M, Farris D, Yeomans L . 1D-¹H-nuclear magnetic resonance metabolomics reveals age-related changes in metabolites associated with experimental venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2016; 4(2):221-30. DOI: 10.1016/j.jvsv.2015.09.010. View

Zea A, Rodriguez P, Atkins M, Hernandez C, Signoretti S, Zabaleta J . Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005; 65(8):3044-8. DOI: 10.1158/0008-5472.CAN-04-4505. View

Song X, Wang W, Chen S, Chen S, Zhang J, Wang Y . [Application of high performance liquid-ion trap mass spectrometry in analyzing saponins in sodium aescinate]. Zhongguo Zhong Yao Za Zhi. 2017; 41(13):2449-2454. DOI: 10.4268/cjcmm20161313. View

Liu L, Wu X, Wu D, Wang Y, Li P, Sun Y . A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of escin Ia and escin Ib in human plasma: application to a pharmacokinetic study after intravenous administration. Biomed Chromatogr. 2010; 24(12):1309-15. DOI: 10.1002/bmc.1441. View

10.

Fei C, Han Y, Wang Z, Lu D, Li H, Chen W . LC-MS/MS method for quantifying aescinate A and B and assessing their relationship with phlebitis. Anal Biochem. 2022; 646:114636. DOI: 10.1016/j.ab.2022.114636. View

11.

Sirtori C . Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res. 2001; 44(3):183-93. DOI: 10.1006/phrs.2001.0847. View

12.

Wang Y, Han J, Xiong W, Yuan Q, Gu Y, Li J . Evaluation of in vivo antioxidant and immunity enhancing activities of sodium aescinate injection liquid. Molecules. 2012; 17(9):10267-75. PMC: 6268365. DOI: 10.3390/molecules170910267. View

13.

Guijas C, Montenegro-Burke J, Warth B, Spilker M, Siuzdak G . Metabolomics activity screening for identifying metabolites that modulate phenotype. Nat Biotechnol. 2018; 36(4):316-320. PMC: 5937131. DOI: 10.1038/nbt.4101. View

14.

Ticinesi A, Guerra A, Nouvenne A, Meschi T, Maggi S . Disentangling the Complexity of Nutrition, Frailty and Gut Microbial Pathways during Aging: A Focus on Hippuric Acid. Nutrients. 2023; 15(5). PMC: 10005077. DOI: 10.3390/nu15051138. View

15.

Ishibashi R, Tanaka I, Kotani M, Muro S, Goto M, Sugawara A . Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions. Kidney Int. 1999; 56(2):589-600. DOI: 10.1046/j.1523-1755.1999.00566.x. View

16.

Siriwardhana N, Kalupahana N, Cekanova M, LeMieux M, Greer B, Moustaid-Moussa N . Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem. 2013; 24(4):613-23. DOI: 10.1016/j.jnutbio.2012.12.013. View

17.

Eronina T, Chebotareva N, Bazhina S, Makeeva V, Kleymenov S, Kurganov B . Effect of proline on thermal inactivation, denaturation and aggregation of glycogen phosphorylase b from rabbit skeletal muscle. Biophys Chem. 2009; 141(1):66-74. DOI: 10.1016/j.bpc.2008.12.007. View

18.

Oragano C, Patton D, Moore Z . Phlebitis in Intravenous Amiodarone Administration: Incidence and Contributing Factors. Crit Care Nurse. 2019; 39(1):e1-e12. DOI: 10.4037/ccn2019381. View

19.

Apers S, Naessens T, Pieters L, Vlietinck A . Densitometric thin-layer chromatographic determination of aescin in a herbal medicinal product containing Aesculus and Vitis dry extracts. J Chromatogr A. 2005; 1112(1-2):165-70. DOI: 10.1016/j.chroma.2005.10.069. View

20.

Yang Y, Wu Z, Meininger C, Wu G . L-Leucine and NO-mediated cardiovascular function. Amino Acids. 2015; 47(3):435-47. DOI: 10.1007/s00726-014-1904-y. View